FOR THE 16 YEARS THAT DR. BRIAN Westerberg, a Canadian surgeon, worked volunteer missions at the Mulago National Referral Hospital in Kampala, Uganda, scarcity was the norm.
The patients usually exceeded the 1,500 allotted beds. Running water was once cut off when the hospital was unable to pay its bills. Patients often couldn’t access the medication they needed, so on some early trips, Westerberg brought drugs over from Canada. But as low-cost generics made in India and China became widely available through Uganda’s government and international aid agencies in the early 2000s, it seemed at first like the supply issue had been solved.
Then on Feb. 7, 2013, Westerberg examined a feverish 13-year-old boy who had fluid oozing from an ear infection. He suspected bacterial meningitis but couldn’t confirm because the CT scanner was broken. The boy was given intravenous ceftriaxone, an antibiotic that Westerberg thought would cure him. But after four days, the ear was worse. As Westerberg prepared to operate, the boy had a seizure. With the CT scanner working again, Westerberg ordered a scan, which revealed abscesses in the boy’s skull, likely caused by the infection.
When a neurosurgeon looked at the images and declared that surgery was unnecessary and the swelling and abscesses would abate with effective antibiotic treatment, Westerberg was confused. They had already treated the boy with ceftriaxone, which hadn’t worked. His confusion deepened when his colleague suggested they switch to a more expensive version of the drug. Why swap one ceftriaxone for another?
Esta historia es de la edición June 3 - 10, 2019 de Time.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición June 3 - 10, 2019 de Time.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
As employers embrace Al, workers fret-and seek input
THE SWEDISH BUY-NOW-PAY-LATER COMPANY KLARNA has become something of a poster child for the potential benefits of generative artificial intelligence.
Claudia Sheinbaum
A first for Mexico
Afghan women defying the Taliban
WHEN KABUL FELL TO THE TALIBAN, RETURNING Afghanistan to the fundamentalist group's control, women who did not flee faced a reality in which they could no longer be who they are: journalists deleted evidence of their work, artists destroyed their creations, and graduates set fire to their degrees.
The way to a truly restful vacation
TRAVEL CAN DO WONDERS FOR YOUR well-being: expanding your mind, bonding you to loved ones, and connecting you with nature.
SHARING GRIEF AMID WAR
Spring and early summer are difficult times for both Israelis and Palestinians. Israeli Jews move from Passover, the holiday of freedom, to Holocaust Memorial Day, to Memorial Day for Fallen Soldiers and Victims of Terror, to the triumphant celebrations of Independence Day. The days pass with rituals intended to give us a shared meaning as a society and to inculcate and frame Israel's official narrative.
WESTWARD HO, AGAIN
Kevin Costner's risky western epic, Horizon, celebrates the height of the genre without quite getting there itself
DO LESS. IT'S GOOD FOR YOU
Unproductive moments can boost health and happiness
'I don't have faith in doctors anymore!'
How women get pressured into long-term birth control
Strait Talk
TAIWAN'S NEW PRESIDENT LAI CHING-TE IS TAKING A HARD LINE ON CHINA. BEIJING IS NOT AMUSED
How U.S. Commerce Secretary Gina Raimondo is navigating America's AI future
UNTIL MID-2023, ARTIFICIAL INTELLIGENCE was something of a niche topic in Washington, largely confined to small circles of tech-policy wonks.